Header cover image

Finnish (OMX) Life Sciences Industry Analysis

UpdatedJun 01, 2026
DataAggregated Company Financials
Companies1
  • 7D18.7%
  • 3M43.4%
  • 1Y15.1%
  • YTD-12.4%

Over the last 7 days, the Life Sciences industry has dropped 5.1%, driven by declines from every company within the industry. However, the industry is down 11% over the past year. Earnings are forecast to grow by 50% annually.

Industry Valuation and Performance

Has the Finnish Life Sciences Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 02 Jun 2026€88.6m€5.4m-€15,967,000.00n/a-5.5x16.3x
Thu, 30 Apr 2026€40.7m€5.0m-€17,898,000.00n/a-2.3x8.1x
Sat, 28 Mar 2026€50.9m€5.0m-€17,898,000.00n/a-2.8x10.1x
Mon, 23 Feb 2026€63.1m€3.8m-€21,772,927.00n/a-2.9x16.4x
Wed, 21 Jan 2026€79.0m€3.8m-€21,772,927.00n/a-3.6x20.6x
Fri, 19 Dec 2025€88.1m€3.8m-€21,772,927.00n/a-4x22.9x
Sun, 16 Nov 2025€91.0m€4.9m-€21,773,927.00n/a-4.2x18.6x
Tue, 14 Oct 2025€90.6m€4.0m-€22,541,927.00n/a-4x22.9x
Thu, 11 Sep 2025€73.6m€4.0m-€22,541,927.00n/a-3.3x18.6x
Sat, 09 Aug 2025€83.1m€3.9m-€21,820,927.00n/a-3.8x21.1x
Mon, 07 Jul 2025€93.1m€3.9m-€21,820,927.00n/a-4.3x23.6x
Wed, 04 Jun 2025€76.0m€3.9m-€21,820,927.00n/a-3.5x19.3x
Fri, 02 May 2025€84.8m€3.7m-€23,427,927.00n/a-3.6x23.2x
Sun, 30 Mar 2025€101.6m€3.7m-€23,427,927.00n/a-4.3x27.7x
Tue, 25 Feb 2025€106.4m€2.4m-€23,073,874.00n/a-4.6x43.8x
Thu, 23 Jan 2025€109.3m€2.4m-€23,073,874.00n/a-4.7x45x
Sat, 21 Dec 2024€103.7m€2.4m-€23,073,874.00n/a-4.5x42.7x
Mon, 18 Nov 2024€96.5m€2.3m-€21,666,874.00n/a-4.5x42x
Wed, 16 Oct 2024€133.4m€2.3m-€21,666,874.00n/a-6.2x58.1x
Fri, 13 Sep 2024€148.3m€2.3m-€21,666,874.00n/a-6.8x64.6x
Sun, 11 Aug 2024€148.3m€2.4m-€23,231,874.00n/a-6.4x61.2x
Tue, 09 Jul 2024€151.4m€2.4m-€23,231,874.00n/a-6.5x62.4x
Thu, 06 Jun 2024€169.7m€2.6m-€23,231,874.00n/a-7.3x66.5x
Sat, 04 May 2024€176.9m€2.6m-€20,755,874.00n/a-8.5x68.9x
Mon, 01 Apr 2024€212.6m€2.6m-€20,755,874.00n/a-10.2x82.8x
Wed, 28 Feb 2024€223.5m€3.2m-€20,985,848.00n/a-10.7x70.9x
Fri, 26 Jan 2024€161.6m€3.2m-€20,985,848.00n/a-7.7x51.3x
Sun, 24 Dec 2023€126.7m€3.2m-€20,985,848.00n/a-6x40.2x
Tue, 21 Nov 2023€131.8m€3.4m-€22,017,848.00n/a-6x39.2x
Thu, 19 Oct 2023€127.1m€3.4m-€22,017,848.00n/a-5.8x37.8x
Sat, 16 Sep 2023€158.4m€3.4m-€22,017,848.00n/a-7.2x47.1x
Mon, 14 Aug 2023€133.3m€3.5m-€21,271,848.00n/a-6.3x38.4x
Wed, 12 Jul 2023€144.7m€3.5m-€21,271,848.00n/a-6.8x41.7x
Fri, 09 Jun 2023€178.0m€3.5m-€21,271,848.00n/a-8.4x51.3x
Price to Earnings Ratio

-8.4x


Total Market Cap: €178.0mTotal Earnings: -€21,271,848.00Total Revenue: €3.5mTotal Market Cap vs Earnings and Revenue0%0%0%
Finnish Life Sciences Industry Price to Earnings3Y Average -5.6x202420252026
Current Industry PE
    There is only one company in the Finnish Life Sciences industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
  • The earnings for companies in the Life Sciences industry have improved over the last three years.
  • Revenues for these companies have grown 15% per year.
  • This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.

Industry Trends

Which industries have driven the changes within the Finnish Healthcare industry?

FI Market-0.76%
Healthcare-0.81%
Life Sciences18.71%
Clinical Research and Equipment18.71%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
NANOFH Nanoform Finland Oyj€1.0717.8%
+€13.9m
19.2%PS16.9x

Latest News